Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutations in the Fas Antigen in Patients With Multiple Myeloma

1 Dec 1997

Abstract excerpt

Programmed cell death, or apoptosis, is well documented as a physiological means of eliminating activated lymphocytes and maintaining immune homeostasis. Apoptosis has also been implicated in the targeting of tumor cells by cytotoxic T lymphocytes and natural killer cells. One of the two primary mechanisms used in cell-mediated cytotoxicity is the Fas/FasLigand system. Activated or transformed cells expressing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell death mechanisms and regulation
Share to Multiple Myeloma Research and Treatments
Share to Natural Compounds in Disease Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 9373236
DOI: 10.1182/blood.v90.11.4266.4266_4266_4270

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutations in the Fas Antigen in Patients With Multiple MyelomaPMID 9373236Read ↗

Mutations in the Fas Antigen in Patients With Multiple MyelomaSemantic proximity Read ↗

Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity.Semantic proximity Read ↗

A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndromeSemantic proximity Read ↗

Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.Semantic proximity Read ↗

Oncogenes in multiple myeloma: point mutation of N-ras.Semantic proximity Read ↗

Analysis of FAS (CD95) gene mutations in higher-grade transformation of follicle center lymphoma.Semantic proximity Read ↗

Mutations in the Fas antigen gene in lpr mice.Semantic proximity Read ↗

Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type IaSemantic proximity Read ↗

Farnesyl transferase inhibitors enhance death receptor signals and induce apoptosis in multiple myeloma cells.Semantic proximity Read ↗

Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional status.Semantic proximity Read ↗

Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci.Semantic proximity Read ↗

A new alternative splice variant of the mouse Fas antigen with a deletion in the N-terminal portion of the extracellular domain.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.